Fig. S32a-a’’, c–c’’), while Tau-5 labelled PSP lesions, where it yielded a strong immunoreactive signal, but failed to label Tau in AD and PiD lesions altogether (Supp. The gene discussed is MAPT; the disease is Alzheimer disease.